State Of Wyoming Moderna, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $97,525 - $132,116	823 New	823 $99,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $89,260 - $146,800	-756 Reduced 78.34%	209 $25,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $66,295 - $99,949	-566 Reduced 36.97%	965 $138,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $77,646 - $144,320	614 Added 66.96%	1,531 $264,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $1,580 - $2,579	-7 Reduced 0.76%	917 $233,000
Q3 2021 Feb 11, 2022	BUY	$221.9 - $484.47 $155,551 - $339,613	701 Added 314.35%	924 $356,000
Q2 2021 Feb 11, 2022	BUY	$129.91 - $234.98 $28,969 - $52,400	223 New	223 $52,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.